Friedman, Debra L.
Vanderbilt-Ingram Cancer Center,
United States
2025 Rank: 134967
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4097 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 134967 | 131753 |
| Total Cites | 987 | 1107 |
| H-index | 15 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 68 | 77 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 148 | 165 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 840 | 907 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.22 |
| Self-Citation Percentage |
10.84%
|
|
Friedman, Debra L.
Vanderbilt University Medical Center,
United States
2024 Rank: 165246
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5434 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 165246 | 149336 |
| Total Cites | 816 | 950 |
| H-index | 12 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 68 | 80 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 150 | 169 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 684 | 758 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.25 |
| Self-Citation Percentage |
14.11%
|
|
Friedman, Debra L.
Vanderbilt-Ingram Cancer Center,
United States
2023 Rank: 99477
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3536 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 99477 | 102764 |
| Total Cites | 955 | 1069 |
| H-index | 15 | 15 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 90 | 106 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 161 | 190 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 780 | 841 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.27 |
| Self-Citation Percentage |
10.66%
|
|
Friedman, Debra L.
Vanderbilt-Ingram Cancer Center,
United States
2022 Rank: 112873
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4232 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 112873 | 106828 |
| Total Cites | 900 | 1059 |
| H-index | 13 | 14 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 80 | 92 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 152 | 170 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 744 | 818 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.29 |
| Self-Citation Percentage |
15.01%
|
|
Friedman, Debra L.
Vanderbilt University Medical Center,
United States
2021 Rank: 136751
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4890 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 136751 | 135535 |
| Total Cites | 1299 | 1472 |
| H-index | 15 | 17 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 119 | 138 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 223 | 250 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1063 | 1151 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.28 |
| Self-Citation Percentage |
11.75%
|
|
Friedman, Debra L.
Vanderbilt-Ingram Cancer Center,
United States
2020 Rank: 122165
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4241 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 122165 | 116805 |
| Total Cites | 1005 | 1114 |
| H-index | 13 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 97 | 108 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 201 | 220 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 775 | 836 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.33 |
| Self-Citation Percentage |
9.78%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.